Linden Advisors’s Revelation Biosciences Warrant REVBW Stock Holding History

Linden Advisors’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63K	Hold	338,110	–	–	﹤0.01%	562
2025 Q4	$2.41K	Hold	338,110	–	–	﹤0.01%	471
2025 Q3	$3.91K	Hold	338,110	–	–	﹤0.01%	404
2025 Q2	$4K	Hold	338,110	–	–	﹤0.01%	375
2025 Q1	$3.7K	Hold	338,110	–	–	﹤0.01%	302
2024 Q4	$2.51K	Hold	338,110	–	–	﹤0.01%	260
2024 Q3	$5.07K	Hold	338,110	–	–	﹤0.01%	264
2024 Q2	$5.8K	Hold	338,110	–	–	﹤0.01%	277
2024 Q1	$9.09K	Sell	338,110 -377,642	-53%	-$5.21K	﹤0.01%	289
2023 Q4	$8.86K	Hold	715,752	–	–	﹤0.01%	293
2023 Q3	$10.6K	Hold	715,752	–	–	﹤0.01%	334
2023 Q2	$12.8K	Hold	715,752	–	–	﹤0.01%	347
2023 Q1	$12.8K	Hold	715,752	–	–	﹤0.01%	415
2022 Q4	$9.25K	Hold	715,752	–	–	﹤0.01%	500
2022 Q3	$36K	Buy	715,752 +378,000	+112%	+$30.7K	﹤0.01%	546
2022 Q2	$26K	Sell	337,752 -378,000	-53%	-$31.7K	﹤0.01%	641
2022 Q1	$86K	Buy	715,752 +56,926	+9%	+$14.5K	﹤0.01%	599
2021 Q4	$452K	Hold	658,826	–	–	﹤0.01%	561
2021 Q3	$412K	Hold	658,826	–	–	﹤0.01%	493
2021 Q2	$419K	Hold	658,826	–	–	﹤0.01%	571
2021 Q1	$343K	Sell	658,826 -20,174	-3%	-$18.9K	﹤0.01%	612
2020 Q4	$591K	Buy	+679,000	New	+$463K	﹤0.01%	413

Other funds holding REVBW

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QWM

Quaker Wealth Management Moorestown, New Jersey $320M AUM 13.7% 1-Year Est. Return

Linden Advisors's REVBW Position: Q1 2026 in Review

Linden Advisors held its Revelation Biosciences Warrant (REVBW) position steady in Q1 2026 at 338,110 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Linden Advisors first reported a position in REVBW in Q4 2020 and has held it in 22 quarters since. The position peaked at $591K in Q4 2020. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

Linden Advisors held 338,110 shares of Revelation Biosciences Warrant worth $2.63K as of Q1 2026.
Linden Advisors left its Revelation Biosciences Warrant share count unchanged in Q1 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #562 holding.
Linden Advisors first reported a position in Revelation Biosciences Warrant in Q4 2020 and has held it in 22 quarters since.
Linden Advisors's Revelation Biosciences Warrant position peaked at $591K in Q4 2020.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.